Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Jazz Pharmaceuticals (Nasdaq: JAZZ) will participate in two investor conferences in March 2026: TD Cowen 46th Annual Health Care Conference on March 3, 2026 and Barclays 28th Annual Global Healthcare Conference on March 12, 2026.
Rhea-AI Summary
Jazz Pharmaceuticals (Nasdaq: JAZZ) will participate in two investor conferences in March 2026: TD Cowen 46th Annual Health Care Conference on March 3, 2026 and Barclays 28th Annual Global Healthcare Conference on March 12, 2026.
Fireside chat times: March 3 at 7:30 a.m. PT / 10:30 a.m. ET / 2:30 p.m. GMT, and March 12 at 7:00 a.m. PT / 10:00 a.m. ET / 2:00 p.m. GMT. An audio webcast and a replay archived for 30 days will be available via the company's Investors website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – JAZZ
On Feb 18, the first trading day after this news, JAZZ closed 0.44% above the previous close.
Data tracked by StockTitan Argus for the Feb 18 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026
- Fireside chat at 7:30 a.m. PT / 10:30 a.m. ET / 2:30 p.m. GMT
Barclays 28th Annual Global Healthcare Conference on Thursday, March 12, 2026
- Fireside chat at 7:00 a.m. PT / 10:00 a.m. ET / 2:00 p.m. GMT
An audio webcast of both fireside chats will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Contacts:
Investors:
InvestorInfo@jazzpharma.com
Media:
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-investor-conferences-302689876.html
SOURCE Jazz Pharmaceuticals plc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
